GGrantIndex
Sort

21,281 grants matching influenza

Innate Immunity in the Clearance of Influenza A Virus Infected Apoptotic Cells

$205,541
Kazue Takahashi · Massachusetts General Hospital · R21 · FY2008 · AI

Data Management and Resources Dissemination Core

$205,471
Sumit K Chanda · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI

Administrative Core

$205,428
Monica Kraft · University Of Arizona · U19 · FY2023 · AI

GLYCOCONJUGATES IN VIRAL PATHOGENESIS

$205,347
University Of Oklahoma Hlth Sciences Ctr · R01 · FY2000 · AI

Hazardous Materials Worker Health and Safety Training (U45), Cooperative Agreement

$205,215
David Turcotte · University Of Massachusetts Lowell · U45 · FY2023 · ES

NOVEL REVERSE ADJUVANT FOR VACCINE ENHANCEMENT

$205,159
Ian Nicholas Crispe · Seattle Biomedical Research Institute · R21 · FY2010 · AI

Investigating Plasmodium vaccination in 'dirty' mice

$205,125
Kristina Stoermer Burrack · Hennepin Healthcare Research Institute · R21 · FY2025 · AI

Informatics for empirically supported influenza pandemic control strategies

$205,124
John S. Brownstein · Boston Children'S Hospital · R21 · FY2007 · LM

The Host Genetics of Age-Dependent Susceptibility

$205,083
Vineet D Menachery · University Of Texas Med Br Galveston · R21 · FY2021 · AI

Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy

$205,000
Abraham P Lee · University Of California-Irvine · R33 · FY2024 · CA

Does the senescent environment contribute to age-related changes in T cell function?

$205,000
Laura Haynes · University Of Connecticut Sch Of Med/Dnt · R21 · FY2020 · AG

Sex Differences in Protective Immunity Against Influenza A Viruses

$205,000
Sabra L Klein · Johns Hopkins University · R21 · FY2010 · AI

Understand the molecular mechanism of age-associated decline in antiviral CD8 T cell immunity

$205,000
Tuoqi Wu · Ut Southwestern Medical Center · R21 · FY2023 · AG

Gender Factors Influencing Susceptability to Influenza

$205,000
Sabra L Klein · Johns Hopkins University · R21 · FY2010 · AI

Development of an influenza A virus and Aspergillus fumigatus coinfection model

$205,000
Joshua J Obar · Dartmouth College · R21 · FY2021 · AI

Can Senolytics Improve the Aged Response to Viral Infection

$205,000
Laura Haynes · University Of Connecticut Sch Of Med/Dnt · R21 · FY2022 · AG

Administrative Equipment Supplement to Enabling Technology to Screen and Quantify Sialylated Structures for Activity Against Viral Enzymes and Receptors

$205,000
Lisa A Holland · West Virginia University · R01 · FY2021 · GM

Novel Approach to Oral Gene Therapy for Chronic Granulomatous Disease

$204,896
Peter E Newburger · Univ Of Massachusetts Med Sch Worcester · R21 · FY2009 · AI

Novel TLR-4 Agonists as Vaccine Adjuvants

$204,860
Alan Thomas Johnson · Hawaii Biotech, Inc. · R43 · FY2024 · AI

CD4 T cell protection and pathology in the lung

$204,820
Trudeau Institute, Inc. · P01 · FY2005 · HL

NLR control of antiviral defense in the respiratory mucosa

$204,806
Akiko Iwasaki · Yale University · R21 · FY2010 · AI

Molecular Diagnosis of Defective Memory Differentiation in Tumor-Specific T Cells

$204,800
William Nicholas Haining · Dana-Farber Cancer Inst · R21 · FY2008 · CA

PLURIPOTENT STEM CELL-BASED IMMUNOTHERAPIES

$204,790
Deepta Bhattacharya · University Of Arizona · R21 · FY2018 · AI

Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity

$204,750
Michael Schotsaert · Icahn School Of Medicine At Mount Sinai · R21 · FY2024 · AI

Mechanisms of immunopathology of COVID-19/ARDS, and strategies to mitigate detrimental inflammatory responses

$204,714
Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI